Capnocytophaga in the dental plaque of immunocompromised children with cancer

International Journal of Paediatric Dentistry

Volumn 16, Issue 2, 2006, Pages 75-80

  Sixou, J L ^a,b   Aubry Leuliette, A ^a,b   De Medeiros Battista, O ^c   Lejeune, S ^a   Jolivet Gougeon, A ^b   Solhi Pinsard, H ^b   Gandemer, V ^d   Barbosa Rogier, M ^a   Bonnaure Mallet, M ^a,b  

^a Department of Paediatric Dentistry ^*  (France)

^b UNIVERSITÉ DE RENNES 1   (France)

^c FEDERAL UNIVERSITY OF PARAÍBA   (Brazil)

^d RENNES UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; COTRIMOXAZOLE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; ARTICLE; BACTERIAL COUNT; CAPNOCYTOPHAGA; CASE CONTROL STUDY; CHI SQUARE DISTRIBUTION; CHILD; DRUG EFFECT; DRUG RESISTANCE; FEMALE; HUMAN; IMMUNE DEFICIENCY; ISOLATION AND PURIFICATION; LYMPHOMA; MALE; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; NONPARAMETRIC TEST; PRESCHOOL CHILD; TOOTH PLAQUE;

ADOLESCENT; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; CAPNOCYTOPHAGA; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; COLONY COUNT, MICROBIAL; DENTAL PLAQUE; DRUG RESISTANCE; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIA, MYELOCYTIC, ACUTE; LYMPHOMA; MALE; MICROBIAL SENSITIVITY TESTS; STATISTICS, NONPARAMETRIC; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 33645121747     PISSN: 09607439     EISSN: 1365263X     Source Type: Journal    
DOI: 10.1111/j.1365-263X.2006.00697.x     Document Type: Article

References (37)

1. Sixou JL De Medeiros-Batista O Gandemer V Bonnaure-Mallet M. The effect of chemotherapy on the supragingival plaque of pediatric cancer patients. Oral Oncology 1998 34 476 483.
2. Kamma JJ Diamanti-Kipioti A Nakou M Mitsis FJ. Profile of subgingival microbiota in children with mixed dentition. Oral Microbiology and Immunology 2000 15 103 111.
3. Könönen E. Development of oral bacterial flora in young children. Annals of Medicine 2000 32 107 112.
4. Elting LS Rubenstein EB Rolston KV Bodey GP. Outcomes of bacteremia in patients with cancer and neutropenia: observations from two decades of epidemiological and clinical trials. Clinical Infectious Diseases 1997 25 247 259.
5. Maury S Leblanc T Rousselot P Legrand P Arlet G Cordonnier C. Bacteremia due to Capnocytophaga species in patients with neutropenia: high frequency of beta-lactamase-producing strains. Clinical Infectious Diseases 1999 28 1172 1174.
6. Ammann RA Hirt A Luthy AR Aebi C. Predicting bacteremia in children with fever and chemotherapy-induced neutropenia. Pediatric Infectious Disease Journal 2004 23 61 67.
7. Gomez-Garces JL Alos JI Sanchez J Cogollos R. Bacteremia by multidrug-resistant Capnocytophaga sputigena. Journal of Clinical Microbiology 1994 32 1067 1069.
8. Kristensen B Schonheyder HC Peterslund NA Rosthoj S Clausen N Frederiksen W. Capnocytophaga (Capnocytophaga ochracea group) bacteremia in hematological patients with profound granulocytopenia. Scandinavian Journal of Infectious Diseases 1995 27 153 155.
9. Lopez R Martino R Pericas R Altes A Sureda A Brunet S. Capnocytophaga bacteremia in neutropenic patients: report of two cases. Acta Haematologica 1994 92 46 47.
10. Parenti DM Snydman DR. Capnocytophaga species: infections in nonimmunocompromised and immunocompromised hosts. Journal of Infectious Diseases 1985 151 140 147.
11. Martino R Ramila E Capdevila JA et al. Bacteremia caused by Capnocytophaga species in patients with neutropenia and cancer: results of a multicenter study. Journal of Infectious Diseases 2001 33 E20 E22.
12. Jolivet-Gougeon A Buffet A Dupuy C et al. In vitro susceptibilities of Capnocytophaga isolates to beta-lactam antibiotics and beta-lactamase inhibitors. Antimicrobial Agents and Chemotherapy 2000 44 3186 3188.
13. Rosenau A Cattier B Gousset N Harriau P Philippon A Quentin R. Capnocytophaga ochracea: characterization of a plasmid-encoded extended-spectrum TEM-17 beta-lactamase in the phylum Flavobacter-bacteroides. Antimicrobial Agents and Chemotherapy 2000 44 760 762.
14. Fayle SA Curzon MEJ. Oral complications in pediatric oncology patients. Pediatric Dentistry 1991 13 289 295.
15. Bonnaure-Mallet M Bunetel L Tricot-Doleux S Guerin J Bergeron C LeGall E. Oral complications during treatment of malignant diseases in childhood: effects of tooth brushing. European Journal of Cancer 1998 34 1588 1591.
16. Epstein JB Schubert MM. Oropharyngeal mucositis in cancer therapy: review of pathogenesis, diagnosis, and management. Oncology (Huntingt) 2003 17 1767 1779.
17. Scully C Epstein J Sonis S. Oral mucositis: a challenging complication of radiotherapy, chemotherapy, and radiochemotherapy. Part 2: diagnosis and management of mucositis. Head and Neck 2004 26 77 84.
18. Silness J Loe H. Periodontal disease in pregnancy. II. Correlation between oral hygiene and periodontal condition. Acta Odontologica Scandinavica 1963 22 122 135.
19. Loe H Silness J. Periodontal disease in pregnancy: prevalence and severity. Acta Odontologica Scandinavica 1964 21 533 551.
20. Eilers J Berger AM Petersen MC. Development, testing, and application of the oral assessment guide. Oncology Nursing Forum 1988 15 325 230.
21. Cheng KK Chang AM Yuen MP. Prevention of oral mucositis in paediatric patients treated with chemotherapy: a randomised crossover trial comparing two protocols of oral care. European Journal of Cancer 2004 40 1208 1016.
22. Syed SA Loesche WJ Pope HL Grenier E. Predominant cultivable flora isolated from human root surface caries plaque. Infection and Immunity 1972 11 721 731.
23. Mashimo PA Yamamoto Y Nakamura M Slots J. Selective recovery of oral Capnocytophaga spp. with sheep blood agar containing bacitracin and polymixin B. Journal of Clinical Microbiology 1983 17 187 191.
24. Slots J. Selective medium for isolation of Actinobacillus actinomycetemcomitans. Journal of Clinical Microbiology 1982 15 606 609.
25. Laughon BE Syed SA Loesche WJ. API ZYM system for identification of Bacteroides spp., Capnocytophaga spp., and spirochetes of oral origin. Journal of Clinical Microbiology 1982 15 97 102.
26. Leadbetter ER Holt SC Socransky SS. Capnocytophaga: new genus of gram-negative gliding bacteria. I. General characteristics, taxonomic considerations and significance. Archives of Microbiology 1979 122 9 16.
27. Yamamoto T Kajiura S Hirai Y Watanabe T. Capnocytophaga haemolytica sp. nov. and Capnocytophaga granulosa sp. nov., from human dental plaque. International Journal of Systematic Bacteriology 1994 44 324 329.
28. Rummens JL Gordts B Van Landuyt HW. In vitro susceptibility of Capnocytophaga species to 29 antimicrobial agents. Antimicrobial Agents and Chemotherapy 1986 30 739 742.
29. National Committee for Clinical Laboratory Standards. Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria: Approved Standard 5th edn. Wayne, PA National Committee for Clinical and Laboratory Standards 2001.
30. Société Française de Microbiologie. Communiqué 2002 du Comité de l'Antibiogramme de la Société Française de Microbiologie (French). Paris Société Française de Microbiologie 2002.
31. Arlet G Sanson-Le Pors MJ Casin IM Ortenberg M Perol Y. In vitro susceptibility of 96 Capnocytophaga strains, including a beta-lactamase producer, to new beta-lactam antibiotics and six quinolones. Antimicrobial Agents and Chemotherapy 1987 31 1283 1284.
32. Baker PJ Evans RT Slots J Genco RJ. Antibiotic susceptibility of anaerobic bacteria from the human oral cavity. Journal of Dental Research 1985 64 1233 1244.
33. Baquero F Fernandez J Dronda F et al. Capnophilic and anaerobic bacteremia in neutropenic patients: an oral source. Review of Infectious Diseases 1990 12 152 160.
34. Forlenza SW Newman MG Horikoshi AL Blachman U. Antimicrobial susceptibility of Capnocytophaga. Antimicrobial Agents and Chemotherapy 1981 19 144 146.
35. Kolokotronis A. Susceptibility of Capnocytophaga to antimicrobial agents. Journal of Chemotherapy 1995 7 414 416.
36. Roscoe DL Zemcov SJ Thornber D Wise R Clarke AM. Antimicrobial susceptibilities and beta-lactamase characterization of Capnocytophaga species. Antimicrobial Agents and Chemotherapy 1992 36 2197 2200.
37. Sutter VL Jones MJ Ghoneim AT. Antimicrobial susceptibilities of bacteria associated with periodontal disease. Antimicrobial Agents and Chemotherapy 1983 23 483 486.